Life sciences business leader and drug discovery expert Chris Molloy to lead Medicines Discovery Catapult technology and innovation centre.
The first chief executive of the Medicines Discovery Catapult Chris Molloy has pledged to lead an organisation that will shape drug discovery and development in the UK and help others to do the same.
Chris said “Fundamental to the Catapult’s mission will be the fact that great people make great R&D, something I have seen throughout my career and recently in advising RSA’s global clients.”
The Catapult will engage the UK’s experienced drug discovery talent and help launch a new generation of drug R&D leaders into a successful future.
It is an incredibly exciting and forward-thinking organisation that will actively shape the direction of travel in drug discovery and development and enable others in the UK to do so too.